Stanek B, Silberbauer K
Acta Med Austriaca. 1984;11(3-4):101-5.
The acute effects of the converting enzyme inhibitor captopril on blood pressure, heart rate and plasma renin activity were assessed in 53 patients (aged 20-80 years) with mild to moderate essential hypertension under basal conditions. The systolic blood pressure before captopril was elevated in patients in the forties (p less than 0,01) when compared to the younger patients and was positively correlated to the age before (r = 0.32, p less than 0.05) and after (r = 0.32, p less than 0,05) angiotensin converting enzyme inhibition with captopril 25 mg. the drop in systolic (-13%) and diastolic (-10%) blood pressure was significantly greater in patients in the fifties (p less than 0,025 and p less than 0,05 respectively) when compared to younger and older (p less than 0,1) patients. The response of plasma renin activity paralleled the blood pressure response, while heart rate after captopril was not significantly changed in any group. The lack of age dependence of the blood pressure response to captopril and of reflex tachycardia suggests converting enzyme inhibition to be a valuable adjunct for the treatment of essential hypertension in the elderly.
在基础条件下,对53例年龄在20至80岁之间的轻至中度原发性高血压患者评估了转换酶抑制剂卡托普利对血压、心率和血浆肾素活性的急性影响。与年轻患者相比,四十多岁患者在服用卡托普利前的收缩压升高(p<0.01),且在服用25mg卡托普利进行血管紧张素转换酶抑制之前(r=0.32,p<0.05)和之后(r=0.32,p<0.05)与年龄呈正相关。与年轻患者和老年患者(p<0.1)相比,五十多岁患者的收缩压下降幅度(-13%)和舒张压下降幅度(-10%)显著更大(分别为p<0.025和p<0.05)。血浆肾素活性的反应与血压反应平行,而任何组服用卡托普利后的心率均无显著变化。血压对卡托普利反应以及反射性心动过速缺乏年龄依赖性,提示转换酶抑制是老年人原发性高血压治疗的一种有价值的辅助手段。